Stay Updated with the Latest Altria Group, Inc. MO News in Real Time
Find MO news now at Meyka AI. Stay informed with the latest Altria Group, Inc. stocks updates, including price news, market analysis, and expert insights.
Qualcomm Inc (NASDAQ: QCOM) Loses 1.86% to $221.90 as AI Expansion Gains Momentum but Stock Faces Pressure
Qualcomm Inc (NASDAQ: QCOM) pulled back 1.86% to $221.90 on June 23, 2026, even as its AI and automotive expansion story grows more concrete by the quarter. The stock trades within a 52-week range of $121.99 to $259.92, reflecting a sharp recovery from lows but still well off its all-time closing high of $250.10 from…
ASX 200 Closes Down 0.33%, Iluka Resources Plunges 10.7% While Temple & Webster Gains 4.2%
The ASX 200 ended June 23, 2026, at 8,800 points, down 0.33% on the session. Tech, mining, and energy sectors led the losses, while logistics, industrial services, and healthcare offered modest support. Investors are also awaiting key US inflation data this week for clues on the Fed’s policy path, while locally, attention is turning to…
Bharti Airtel (NSE: BHARTIARTL) Shares Turn Positive After Increasing Airtel Africa Stake to 79% in ₹28,200 Crore Deal
Bharti Airtel (NSE: BHARTIARTL) shares recovered and turned positive after the company’s landmark ₹28,200 crore Airtel Africa stake consolidation received near-unanimous shareholder approval on June 15, 2026. The deal raises Airtel’s indirect ownership in the Africa business from 62.73% to 79.04%. BHARTIARTL was trading around ₹1,910.80 recently, within a 52-week range of ₹1,740.50 to ₹2,174.50….
Tesla Inc Shares (NASDAQ: TSLA) up +1.14% After Jefferies Lowers Target to $375 Amid SpaceX Merger Talk
Tesla Inc. shares climbed 1.14% after analysts at Jefferies lowered their price target to $375, drawing fresh attention to the company’s future growth path. The move comes as investors closely watch rising speculation about a possible Tesla-SpaceX merger, a topic that has sparked intense debate across Wall Street in June 2026. While some see major…
Vedanta Ltd (NSE: VEDL) Falls 6.67% to ₹285.45 as Promoter Twin Star May Sell ₹2,150 Crore Stake
Vedanta shares took a sharp hit on June 23, 2026, tumbling 6.67% to ₹285.45 on the NSE in early trade. Promoter entity Twin Star Holdings, which held a 40.02% stake in Vedanta as of March 2026, initiated a block deal to offload up to 6.5 crore shares at a floor price of ₹291 per share,…
Voltas Ltd (NSE: VOLTAS) Falls 1.87% to ₹1,328.70 as Company Sells 1 Million AC Units in Q1 FY27
Voltas achieved a major milestone in the first quarter of FY27, selling more than 1 million air conditioners in record time. The announcement came in June 2026, highlighting strong demand for cooling products across India despite a competitive market. Yet, the company’s share price slipped 1.87% to ₹1,328.70, raising questions among investors. Why did the…
Lloyds Banking Group PLC (LON: LLOY) Gains 0.048% as Lloyds Confirms 233 Branch Closures Across the UK
Lloyds Banking Group PLC (LON: LLOY) edged up 0.048% on June 23, 2026, trading at approximately 105.10p. The gain comes on the same day the group formally confirmed 233 branch closures in 2026, with another 12 sites set to follow in early 2027. The banking giant has now closed nearly 1,600 branches across the UK…
Robinhood (NASDAQ: HOOD) Shares Slide 4% After Unveiling $2 Billion Convertible Notes Offering Due 2029
Robinhood shares dropped roughly 4% on June 22, 2026, after the company announced a major capital raise before market open. Robinhood Markets, Inc. (NASDAQ: HOOD) intends to offer $2.0 billion in convertible senior notes due 2029 in a private placement to qualified institutional buyers under Rule 144A. Shares traded at $108.15 on June 22, within…
AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Deal, Offering Nearly 50% Premium
AbbVie made a major move in the biotech sector on June 22, 2026, announcing a $10.9 billion deal to acquire Apogee Therapeutics. The transaction offers Apogee shareholders nearly a 50% premium and gives AbbVie access to a promising pipeline of immunology treatments. As competition grows in the market for inflammatory disease therapies, this acquisition could…